Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy

被引：0
|
作者：
Regina Mühleck
Sebastian Scholl
Inken Hilgendorf
Karin Schrenk
Jakob Hammersen
Jochen J. Frietsch
Maximilian Fleischmann
Herbert G. Sayer
Anita Glaser
Andreas Hochhaus
Ulf Schnetzke
机构：
[1] Universitätsklinikum Jena,Klinik für Innere Medizin II, Abteilung für Hämatologie und Internistische Onkologie
[2] HELIOS Klinikum Erfurt,4. Medizinische Klinik
[3] Universitätsklinikum Jena,Institut für Humangenetik
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
AML; Refractory; Relapse; Salvage therapy; Mito-FLAG;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2539 / 2548
页数：9
相关论文
共 50 条
  • [41] Comparison of salvage chemotherapy regimens and prognostic significance of minimal residual disease in relapsed/refractory acute myeloid leukemia
    Mushtaq, Muhammad Umair
    Harrington, Alexandra M.
    Chaudhary, Sibgha Gull
    Michaelis, Laura C.
    Carlson, Karen-Sue B.
    Abedin, Sameem
    Runass, Lyndsey
    Callander, Natalie S.
    Fallon, Michael J.
    Juckett, Mark
    Hall, Aric C.
    Hematti, Peiman
    Mattison, Ryan J.
    Atallan, Ehab L.
    Murthy, Guru Subramanian Guru
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 158 - 166
  • [42] Predictors of response and outcome in patients with refractory/relapsed acute myeloid leukemia receiving venetoclax with non-intensive chemotherapy
    Kruger, K.
    Wichmann, M.
    Gabdoulline, R.
    Goetze, K. S.
    Braitsch, K.
    Modemann, F.
    Fiedler, W.
    Trummer, A.
    Krauter, J.
    Kaun, S.
    Rotermund, S.
    Voss, A.
    Goehring, G.
    Behrens, Y.
    Thol, F.
    Eder, M.
    Beutel, G.
    Stadler, M.
    Heuser, M.
    Shahswar, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 134 - 134
  • [43] FLAG-(IDA)-Mylotarg in the therapy of relapsed and refractory acute myeloid leukemia.
    Fabbiano, F
    Mondello, F
    Magrin, S
    Felice, R
    Marino, C
    Turri, D
    Mirto, S
    BLOOD, 2005, 106 (11) : 236B - 236B
  • [44] Outcome Of Dose-Adjusted Decitabine Regimen Compared With FLAG Regimen In The Treatment Of Relapsed/Refractory Acute Myeloid Leukemia
    Wu, Qian
    He, Guangsheng
    Wu Depei
    Sun, Aining
    Qiu, Huiying
    Jin, Zhengming
    Miao, Miao
    Tang, XiaoWen
    Han, Yue
    Shen, Yiming
    Chen, Feng
    Hu, Xiaohui
    Jin, Song
    Zhang, Xuhui
    BLOOD, 2013, 122 (21)
  • [45] FLAG and Etoposide as Salvage Treatment in Acute Myeloid Leukemia
    Papadantonakis, Nikolaos
    ACTA HAEMATOLOGICA, 2020, 143 (05) : 403 - 404
  • [46] A retrospective comparison of salvage intensive chemotherapy versus venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML)
    Park, Silvia
    Kwag, Daehun
    Kim, Tong Yoon
    Lee, Jong Hyuk
    Lee, Joon Yeop
    Min, Gi June
    Park, Sung Soo
    Yahng, Seung-Ah
    Jeon, Young-Woo
    Shin, Seung-Hwan
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Cho, Byung Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Lee, Seok
    Min, Chang-Ki
    Cho, Seok-Goo
    Lee, Jong Wook
    Kim, Hee-Je
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [47] Clinical outcomes in patients with relapsed/refractory acute leukemia treated with FLAG-IDA regimen.
    Basquiera, Ana L.
    Prates, M. Virginia
    Sturich, Ana Gabriela
    Berretta, Adriana R.
    Milone, Jorge
    Garcia, Juan
    BLOOD, 2006, 108 (11) : 220B - 220B
  • [48] Outcomes of relapsed or refractory acute myeloid leukemia patients failing venetoclax-based salvage therapies
    Zucenka, Andrius
    Pileckyte, Regina
    Trociukas, Igoris
    Peceliunas, Valdas
    Vaitekenaite, Vilmante
    Maneikis, Kazimieras
    Davainis, Linas
    Zvirblis, Tadas
    Stoskus, Mindaugas
    Gineikiene, Egle
    Norvilas, Rimvydas
    Dirse, Vaidas
    Surauciute, Agne
    Zucenkiene, Emile
    Griskevicius, Laimonas
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (01) : 105 - 113
  • [49] FLAG-IDA Has Significant Activity As Frontline Induction or Salvage Therapy for Patients with High Risk and/or Relapsed or Refractory Acute Myeloid Leukemia (AML)
    Bhella, Sita D.
    Atenafu, Eshetu G.
    Schuh, Andre C.
    Minden, Mark D.
    Schimmer, Aaron D.
    Gupta, Vikas
    Seftel, Matthew D.
    Alam, Naheed
    Lutynski, Andrzej
    Rostom, Amr
    Rydlewski, Anna
    Yee, Karen
    BLOOD, 2014, 124 (21)
  • [50] Retrospective Analysis of Adult Relapsed and Refractory Acute Leukemia Patients Treated with FLAG at a Comprehensive Cancer Center
    Tenold, Matthew
    Moskoff, Benjamin
    Krishnan, Rajeev
    Rosenberg, Aaron Seth
    Jonas, Brian A.
    BLOOD, 2017, 130
12345